UAS Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,700
Closed -$2.9M 14
2025
Q4
$2.9M Buy
+2,700
New +$2.58M 0.61% 11
2024
Q4
Sell
-4,840
Closed -$4.29M 16
2024
Q3
$4.29M Sell
4,840
-7,236
-60% -$6.51M 1.04% 9
2024
Q2
$10.9M Buy
12,076
+4,466
+59% +$3.57M 2.62% 9
2024
Q1
$5.92M Buy
7,610
+3,410
+81% +$2.43M 1.58% 8
2023
Q4
$2.45M Buy
+4,200
New +$2.45M 0.62% 12

Other funds holding LLY

UAS Asset Management's LLY Position: Q1 2026 in Review

UAS Asset Management sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 2,700 shares — an estimated $2.9M sold.

UAS Asset Management first reported a position in LLY in Q4 2023 and held it in 5 quarters. The position peaked at $10.9M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • UAS Asset Management reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • UAS Asset Management sold 2,700 Eli Lilly shares in Q1 2026, an estimated $2.9M.
  • UAS Asset Management first reported a position in Eli Lilly in Q4 2023 and held it in 5 quarters.
  • UAS Asset Management's Eli Lilly position peaked at $10.9M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on UAS Asset Management's 13F filing for Q1 2026, filed 14 May 2026.